Literature DB >> 27363691

Ten-year follow-up of health-related quality of life among ambulatory persons with multiple sclerosis at baseline.

Aki Rintala1, Arja Häkkinen1,2, Jaana Paltamaa3.   

Abstract

PURPOSE: The aim of this 10-year follow-up study was to determine changes in health-related quality of life (HRQoL) over time among ambulatory persons with MS (PwMS) at the baseline using generic and disease-specific instruments.
METHODS: Of 109 independently walking PwMS included in a population-based study in 2002, 77 (70.6 %) were re-assessed in 2012. HRQoL was captured using the 36-Item Short Form Survey Instrument (RAND-36), 15D instrument (15D), and the Multiple Sclerosis Quality of Life-54 (MSQOL-54). Repeated-measures ANOVA and effect size (ES) calculations (Cohen's d) were used in the statistical analysis.
RESULTS: The RAND-36 physical health composite score (p = 0.003, ES = 0.26) and 15D total score (p = 0.012, ES = 0.25) declined from the baseline levels. In particular, lower scores were observed on the RAND-36 scales of physical functioning (p = 0.001, ES = 0.27), pain (p = 0.020, ES = 0.25), and general health perceptions (p = 0.002, ES = 0.36), on the MSQOL-54 scales of physical functioning (p = 0.001, ES = 0.27), pain (p = 0.040, ES = 0.21), sexual functioning (p = 0.003, ES = 0.43), and satisfaction with sexual functioning (p = 0.012, ES = 0.38), and in the 15D dimensions of mobility (p = 0.004, ES = 0.31) and sexual functioning (p ≤ 0.001, ES = 0.59). Improvement was observed on the RAND-36 scale of social functioning (p = 0.049, ES = 0.25). The other composite scores, scales, and dimensions remained unchanged.
CONCLUSION: The results of this study suggest that ambulatory PwMS at baseline reported reduced HRQoL in physical functioning after a 10-year follow-up period, while emotional well-being was maintained and social functioning improved. The scores in the other HRQoL dimensions and scales remained unchanged. More long-term population-based studies are needed to precisely determine the development of HRQoL among PwMS.

Entities:  

Keywords:  Health-related quality of life; Multiple sclerosis; Patient-reported outcomes; Quality of life

Mesh:

Year:  2016        PMID: 27363691     DOI: 10.1007/s11136-016-1347-x

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  47 in total

1.  Estimating the minimum important change in the 15D scores.

Authors:  Soili Alanne; Risto P Roine; Pirjo Räsänen; Tarja Vainiola; Harri Sintonen
Journal:  Qual Life Res       Date:  2014-08-22       Impact factor: 4.147

2.  Difference between generic and multiple sclerosis-specific quality of life instruments regarding the assessment of treatment efficacy.

Authors:  S Ozakbas; B B Akdede; G Kösehasanogullari; O Aksan; E Idiman
Journal:  J Neurol Sci       Date:  2007-03-26       Impact factor: 3.181

3.  Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: results from a longitudinal study.

Authors:  Francesco Patti; Angelo Pappalardo; Enrico Montanari; Ilaria Pesci; Valeria Barletta; Carlo Pozzilli
Journal:  J Neurol Sci       Date:  2013-12-26       Impact factor: 3.181

4.  A health-related quality of life measure for multiple sclerosis.

Authors:  B G Vickrey; R D Hays; R Harooni; L W Myers; G W Ellison
Journal:  Qual Life Res       Date:  1995-06       Impact factor: 4.147

5.  Multiple sclerosis: change in health-related quality of life over two years.

Authors:  Wilma M Hopman; Helen Coo; Andrey Pavlov; Andrew G Day; Catherine M Edgar; Evelyn V McBride; Donald G Brunet
Journal:  Can J Neurol Sci       Date:  2009-09       Impact factor: 2.104

6.  Longitudinal 7-year follow-up of chronic pain in persons with multiple sclerosis in the community.

Authors:  Fary Khan; Bhasker Amatya; Jürg Kesselring
Journal:  J Neurol       Date:  2013-04-25       Impact factor: 4.849

7.  Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis.

Authors:  K Baumstarck; J Pelletier; H Butzkueven; O Fernández; P Flachenecker; E Idiman; S Stecchi; M Boucekine; P Auquier
Journal:  Eur J Neurol       Date:  2013-01-24       Impact factor: 6.089

8.  Physical activity and quality of life in multiple sclerosis: intermediary roles of disability, fatigue, mood, pain, self-efficacy and social support.

Authors:  Robert W Motl; Edward McAuley; Erin M Snook; Rachael C Gliottoni
Journal:  Psychol Health Med       Date:  2009-01       Impact factor: 2.423

Review 9.  Multiple sclerosis: treating symptoms, and other general medical issues.

Authors:  Myla D Goldman; Jeffrey A Cohen; Robert J Fox; Francois A Bethoux
Journal:  Cleve Clin J Med       Date:  2006-02       Impact factor: 2.321

Review 10.  Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs.

Authors:  Daniël Lakens
Journal:  Front Psychol       Date:  2013-11-26
View more
  2 in total

Review 1.  The Role of Wearable Devices in Multiple Sclerosis.

Authors:  Maddalena Sparaco; Luigi Lavorgna; Renata Conforti; Gioacchino Tedeschi; Simona Bonavita
Journal:  Mult Scler Int       Date:  2018-10-10

2.  Health-related quality of life of multiple sclerosis patients: a European multi-country study.

Authors:  Laurenske A Visser; Celine Louapre; Carin A Uyl-de Groot; William K Redekop
Journal:  Arch Public Health       Date:  2021-03-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.